Posts Tagged ‘R&D’
Friday, June 18th, 2010
Nearly a thing of the past
“Super Asprin” makes it’s mark.
John Gilmer has broken through the aspirin barrier to form this “Super Asprin”. He is now apparently in talks with Solvatrin Theraputics regarding developing the drug.
Solvatrin Theraputics are the company behind what has now been named as “Super Aspirin”, and are in talks with a number of multinational pharma companies.
Based in Cork, the company expects the super product to be “on the shelf” in the next two years. Regulatory approval pending, the sale are set to top €500m in the space of 8 years!
Dr John Gilmer has spent in excess of 10 years working on the “Super Aspirin” believes it will give you all the benefits of aspirin but not the gastro-intestinal bleeding side effect. In order to protect the intestine and stomach lining, Gilmer discovered that he could deactivate the aspirin and re-activate at a later stage by enzymes naturally present in the blood. Basically, the aspirin content content becomes active as soon as it reaches the bloodstream.
“Our research has shown the market demands a solution to the side effects of aspirin and our drug directly addresses this problem” says c0-founder Pat O’Flynn.
It appears that June is a good month for Research, Development and Pharmaceuticals – Gilmer’s 10 years hard work has finally paid off
Tags: aspirin, aspirin side effects, development, drug, drug development, john gilmer, pharma, pharma companies, pharmaceutical, pharmaceutical companies, Pharmaceuticals, R&D, reseach and development, research, solvatrin therapeutics, super aspirin, super product
Posted in Diagnostic Medicine, Life Sciences, Pharmaceuticals, R&D, quality | No Comments »
Wednesday, April 7th, 2010
Nanoscience gets funding
New Jobs in Irish Nanoscience Research?
Nanoscience research institute CRANN is to create new jobs in Research & Development, leading research projects including cancer research and computer chips.
The majority of these seventeen newly created positions are to be in the Institute of Molecular Medicine and TCD School of Medicine in conjunction with CRANN. This particular team will be aiming at nanomedical technology in the early diagnosis of cancer.
The remaining 5 positions are to be with Intel as CRANN focuses on developing computer chips for the next generation.
Professor John Boland, Director of CRANN says “Ireland is now globally recognised for it’s expertise in the area of nanoscience, as evidenced by the large amounts of non-exchequer funding we are winning through competitive international research projects.” He goes on to say “Research is a global competition and we need to contuinue to develop our knowledge base and expertise to make Ireland a true innovation centre”
The investment was seen as a “huge vote of confidence” by Professor Dermot Kelleher of TCD School of Medicine.
Tags: development, irish nanoscience, Nanoscience, nanoscience funding, nanoscience jobs, R&D, R&D Jobs, research, research & development, research & development jobs, research jobs, Science, science jobs
Posted in Biotechnology, Computer Science, Nano Devices, Nanotechnology, R&D, Research and Development, science jobs, semiconductors | No Comments »
Friday, March 12th, 2010
215,000 NEW Science Jobs by 2020. This is the ambitious plan conceived in a report authored by the Innovation Taskforce.
Laser Research has multiple applications-including telecoms and Internet V.2
An element of which will involves a comprehensive and revised broadband roll out, a review of Taxation and Intellectual Property and a strategic review of investment into various domestic and FDI R&D projects incorporating Irish National Technological universities which aims ultimately at turning Ireland into an international innovation hub.
The reports authors who include such luminaries such as Cisco, KPMG, and various high profile software entrepenurs as well as representitives from Enterprise Ireland have given 24 recommendations which will provide a road map for Irelands technological future.
Key of these recommendations is a change in attitude towards failure and entrepenureship which it is hopped will provide a spur to Irish innovation and thus Job creation.
Myscience jobs wishes all success to Irish Entrepeneurs wishing to extend the boundaries of science and technology, and looks forward to the creation of the next generation of science jobs that can only add to Irelands reputation and future prosperity.
Tags: Broadband, CISCO, Enterprise Ireland, Entrepeneurs, FDI, Foreign Direct Investment, Innovation Hub, Innovation Task Force, Intelectual Property, Investment, IP, Irish National Technological Universities, KPMG, Laser Research, myscience jobs, R&D, science jobs, software
Posted in Uncategorized | No Comments »
Monday, February 22nd, 2010
Plastics People Technical skills continue to be in demand
Plastic people -or those persons associated with manufacturing utilising polymer plastics such as PET continue to be in demand in the medical device manufacturing industry.
Positions for catagories such as Moulding Engineer, Manufacturing Engineer, or Production Manager with knowledge of injection moulding are keenly saught after by companies such as KCI, Vistakon and Mergon as these professionals are at the heart of their R&D and CIP stratagies which require cutting edge technology and High Value Added Knowledge and expertise that place Ireland at the same levels of Quality and New Product Development as Singapore, Germany and the US.
Our only weakness it would seem is there just are not enough qualified engineers and managers with plastic knowledge- perhaps we need to stretch our educational resources further to meet the demands of this increasingly lucrative sector?
Tags: CIP, injection, Injection Moulding, KCI, Manufacturing Engineer, Medical Device Manufacturing, Mergon, Moulding, Moulding Engineer, PET, Plastic people, Polymer plastics, production manager, R&D, vistakon
Posted in Manufacturing Engineering, Medical Device Manufacture, Moulding | No Comments »
Monday, January 11th, 2010
Medical Devices Marketing Directors Lead the Way
The Market for Marketing Directors and Managers for Science jobs has broadened and expanded to include almost all science sectors. Medical Device Manufacturing, Pharmaceuticals, Biopharmaceuticals and laterly IC have begun to experience a resurgence of growth that is a positive indicator for the employment prospects of sales and marketing professionals. To date, all have witnessed considerable retrenchment in the technology sectors but no longer is this the case.
Medical Device and Pharmaceuticals manufacturing in Ireland as previously discussed has witnessed steady growth despite a global downturn that has affected most other sectors.
Medical Device Marketing Directors and Managers with expertise in marketing medical devices particularly disposable products are in great demand given the presence of such firms as Teleflex, Merit Medical, Boston Scientific and Medtronic who have seen huge growth in demand for their products.
Additionally, we have witnessed a considerable increase in key positions such as Pharmaceutical Sales and Marketing Manager, Chief Science Officer and Head of Research & Development to aid the development, sales and marketing of these new products for the local and foreign export markets.
New automated manufacturing technologies have also helped to reduce manufacturing costs for these goods and allied to applied R&D in these sectors there have been startling new product developments which have produced corresponding increased profits resulting in a far greater resilient industrial sector engaged in new science job creation centers which are of such vital importance to Ireland’s new smart economy.
Tags: Biopharmaceuticals, Boston Scientific, Chief Science Officers, Disposable products, Head of R&D, IC, Marketing, Medical Device Manufacturing, Medical Device Marketing Managers, Medtronic, Merit Medical, Pharmaceuticals, R&D, Teleflex
Posted in Medical Device Manufacture, R&D, science jobs | No Comments »
Monday, December 21st, 2009
A New Year and New Science Jobs are expected to increase. Last year American firms were the largest investors in
Intel- One of Ireland Inc's Largest R&D Investors
Ireland inc with nearly 2000 additional jobs created across a range of manufacturing and technical service sectors. The US has invested almost $150 Billion in Ireland in the past year with major investments from Intel, Boston Scientific, Teleflex, Pfizer, HP and Abbott to name a few. This investment is showing no immediate sign of diminishing.
Almost 100, 000 people are in full time emplopyment with US multinationals counting for almost 70% of IDA backed projects throughout Ireland with close to 600 firms covering Biopharma, medical devices, semiconductors, precision engineering, software, telecommunications, Pharmaceuticals, Project Management and Engineering firms providing high end design and technical skills that will be the basis for Irelands future smart economy.
2009 was with out doubt one of the hardest years Ireland has endured economically but we possess a wealth of technical and knowledge based skills that translate and compete internationally with the best and brightest from the US, Germany, Japan and Singapore.
R&D invetsment in Ireland both Nationally and internationally has also grown which indicates a level of confidence in the future that looks beyond the recession we have experienced to date. We are definately not out of the woods yet but we can see through the trees to the light beyond. Knowledge will light the way to a brighter future.
Tags: Abbott, biopharma, Boston Scientific, HP, Intel, Medical Devices, pfizer, Pharmceuticals, R&D, science jobs, semiconductors, Teleflex
Posted in Knowledge Economy, Life Sciences, Medical Device Manufacture, R&D | No Comments »
Monday, December 14th, 2009
Medical Device Manufacturing- Product Development- R&D
A €30 million investment in medical devices, R&D and facilities has been made by three seperate multinationals located at three seperate locations around Ireland. This is a superb vote of confidence in Irish R&D and is yet another example of the commitment shown by multinationals to their Irish operations that will see them into and beyond 2010 .
Merit Medical Systems, Sanmina and Baxter Healthcare will continue their FDI investment program of over €30 Million in further R&D and facilties expansion projects and cover a number of disparate projects.
Merit who manufacture proprietory disposable medical devices for diagnostic and interventional procedures worldwide will be investing €20 million in a new product and upgrading others at their Galway manufacturing facility. This will lead to greater diversity and enhancements in the current production facilities and product lines and add considerable value .
Baxter Healthcare will add a €5.5 Million new CHP (Combined Heat and Power) plant to their Castlebar plant which will account for almost 75% of its energy requirements and reduce their operating costs substantially.
Elsewhere in the country, Sanmina in Fermoy are investing €10 million in their electronic medical devices manufacturing facility. Fermoy is seen as the leading R&D facility within Sanmina and will be enhancing and further developing the current R&D facilities to account and cover for outsourced design, development and manufacturing for OEM (Original Engineering Manufacturing) Clients. Sanmina will now employ just under 500 persons as a result of this investment and indicates the continued level of importance placed on the Fermoy facility within the Sanmina corporate structure.
Happy 2010 to all!
Tags: disposable medical devices, Electronic Medical Devicves, Medical Devices Manufacturing Jobs, R&D
Posted in Medical Device Manufacture, Medical Science, R&D, Research and Development | No Comments »
Monday, December 7th, 2009
Irish R&D competing and contributing globally
Ireland is punching above it’s weight as its continues to gather more than its share of foreign direct investment in Research and Development. FDI for R&D for the majority of countries worldwide is down by 30% yet Ireland continues to attract major R&D funding from global investors. As previously stated in this blog, as disparate technologies such as medical devices, ICT, biopharma and pharma converge, commercial opportunities continue to expand and Ireland has positioned itself excellently to take advantage.
Nanotechnology is one field that because of significant recent developments within life sciences technologies is expected to grow in business opportunities worldwide to a figure of just over $3 Trillion from a figure of just under $150 Billion by 2015.
As things stand currently, Ireland is competing strongly against significant international established players such as Israel, Singapore, Germany and the US and yet we continue to gain a considerable portion of international funding available for investment.
Last year alone 80% of all Irish exports were life science or IT related. Of this Multinationals contributed to 73% of R&D spent in the country with €19 Billion of this expenditure spent directly in the Irish economy.
Impressive figues and statistics by any interpretation and a clear indicator that Ireland continues to attract high value projects and opportunities for high skill, high value jobs. Given the current economic climatic conditions we are experiencing this is very good news indeed-long may it continue.
Tags: ICT, Life Science, Medical Devices, Nanotechnology, R&D, Research and Development
Posted in Medical Device Manufacture, Nano Devices, Nanotechnology, R&D | No Comments »
Thursday, December 3rd, 2009
Green technology applications only limited by our imagination
80,000 Green Jobs for Ireland! Thats the target in a report commissioned by the governments High Level Action Group centering on the global $700 Billion Green economy.
Innovation is the key to developing these jobs in the Green enterprise sector as part of a series of renewal projects aimed at recovering the Irish Economy. The strategy is aimed at attracting investment and creating long term sustainable jobs which will contribute to long term growth.
The Global market for Green services and products is estimated in the regions of $700 Billion and will exceed this by 2010. As it stands, the Irish economy’s share of this is close to $3 Billion with potential for further growth.
The private and public sector currently accounts for almost $30 Billion investment in infrastructure and energy projects which if Ireland acts quickly could mean Ireland seeing significant further market share gains as competition for opportunities and investment in this sector increases across the globe.
Already Ireland is actively involved with and targeting areas such as; World Class Green R&D, Energy Conservation Projects, Renewable Energy, , Green Procurement, Waste Managment, Waste Water Treatment and Green Enterprise Zones.
The future is bright the future is Green.
Tags: Green Jobs, Investment, Irish Economy, R&D, Renewable Energy, Waste management, Waste Water Treatment
Posted in Green Jobs, R&D, Renewable Energy | No Comments »
Monday, November 30th, 2009
NanoDevice Micromesh
Nanodevice Medical Devices Make Big News in Ireland. As previously mentioned on this blog, Medical devices continue to be a major center of growth and activity both in R&D and job creation for the Irish economy. But allied to this power house another developing science is begining to make itself felt. Nanoscience is rapidly converging and combining with the BioPharma and Medical device sectors which were once seen as distinct and completely sepperate branches of science and are now adding incredible synergies. Medical devices and biopharma products are now being enhanced and expanded far beyond their existing or previously envisioned applications into new and advanced medical or clinical applications. They have also opened up completly new research vistas undreamt of less than five years ago.
Nanoscience adds a different dimension or perhaps microdimension to products such as medical devices that allows them to operate at the subatomic level. For instance, as we see with most medical devices at present they operate as simple tools treating the symptoms of ailments whereas we are already witnessing the application of nanoscience to medical devices that will very soon actually allow them to actively cure an illness.
Specifically we can envisage the usage of nano robots that can heal tears in arteries unreachable by contemporary surgery techniques. Additionally early research is already being undertaken with the development of gold plated nano drugs capable of functioning as effectively as a smart bio weapon, guided precisely and unerringly to the point of infection such as cancerous tumours doing away with debilitating chemo or radiation therapy.
Added together, medical devices, ICT and Biopharma employ over 130,000 people emphasising their importance to the nation as a significant economic driver. Given the global market for nanoscience products is over €3 Trillion Dollars, or to localise this figure, last year Ireland exported over €150 Billion in goods and services, of this 10% were nanoscience enabled or related products or €15 Billion. By 2015 this figure could be as much as €30 Billion.
Small wonder then that as this sector continues to grow in importance, it will continue to be a beacon of hope in a time of unprecedented economic gloom.
Tags: biopharma, Cancer Research, Engineering jobs, Gold, ICT, Ireland, Irish Economy, Jackie Brown Medical, Medical Devices, Medical Jobs, Nano Drugs, nanodevice, Nanoscience, R&D, Science applications, science jobs, Technical Jobs
Posted in Medical Device Manufacture, Medical Science, Nano Devices, Uncategorized | No Comments »
